Colgate-Palmolive (CL) analyst forecast and price target
Analyst forecast
Consensus of 24 analyst ratings
Based on 8 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Equal-Weight | $90.00 from $95.00 | Oct 5, 2026 |
| Piper Sandler | Maintained | Overweight | $95.00 from $98.00 | Sep 21, 2026 |
| RBC Capital | Maintained | Outperform | $104.00 | Sep 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $101.00 from $100.00 | Aug 3, 2026 |
| RBC Capital | Maintained | Outperform | $104.00 from $102.00 | Aug 3, 2026 |
| JP Morgan | Maintained | Overweight | $103.00 from $104.00 | Aug 3, 2026 |
| TD Cowen | Maintained | Hold | $90.00 from $85.00 | Aug 3, 2026 |
| UBS | Maintained | Buy | $109.00 from $106.00 | Aug 3, 2026 |
| Barclays | Maintained | Equal-Weight | $87.00 from $80.00 | Jul 21, 2026 |
| UBS | Maintained | Buy | $106.00 from $100.00 | Jul 16, 2026 |
| JP Morgan | Maintained | Overweight | $104.00 from $96.00 | Jul 16, 2026 |
| Citigroup | Maintained | Buy | $110.00 from $105.00 | Jul 14, 2026 |
| Piper Sandler | Maintained | Overweight | $96.00 from $92.00 | Jul 9, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $95.00 from $92.00 | Jul 8, 2026 |
| Bernstein | Initiated Coverage | Market Perform | $96.00 | Jun 11, 2026 |
| Barclays | Maintained | Equal-Weight | $80.00 from $79.00 | May 5, 2026 |
| RBC Capital | Maintained | Outperform | $102.00 | May 4, 2026 |
| UBS | Maintained | Buy | $100.00 from $98.00 | May 4, 2026 |
| JP Morgan | Maintained | Overweight | $96.00 from $95.00 | May 4, 2026 |
| Morgan Stanley | Maintained | Overweight | $95.00 from $100.00 | Apr 23, 2026 |
Frequently asked questions
What is the price target for CL stock?
The average 12-month analyst price target for Colgate-Palmolive (CL) is $97.38, with a high estimate of $109.00 and a low of $87.00, across 8 analysts.
Is CL a buy, sell, or hold?
Analysts covering Colgate-Palmolive currently average a Buy rating: 13 buy, 11 hold and 0 sell, from 24 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CL?
The average price target of $97.38 implies 4.95% upside from the last price of $92.78.
What is the latest analyst rating on CL?
On Oct 5, 2026, Wells Fargo maintained Colgate-Palmolive at Equal-Weight with a price target of $90.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.